# Tristel plc Q4 2026 Earnings Call

> Tristel plc CEO Chris Lee shares high-level disinfection chemistry results for Q4 2026.
- Title: Tristel plc Q4 2026 Earnings Call · Seekingalpha | Shortify
- Summary: Tristel plc CEO Chris Lee shares high-level disinfection chemistry results for Q4 2026. Tristel plc's CEO Chris Lee presented Q4 2026 earnings with a focus…
- Keywords: tristel plc, tsnlf, chlorine dioxide, q4 2026, earnings call, ceo, chlorine dioxide disinfection, money, business, Tristel, plc, 2026
- Source: Seekingalpha — https://seekingalpha.com/article/4955297-tristel-plc-tsnlf-q4-2026-earnings-call-transcript
- Author: SA Transcripts
- Published: 2026-10-19T18:53:59+00:00
- Read time: 1 min
- Topics: tristel plc, tsnlf, chlorine dioxide, q4 2026, earnings call, ceo, chlorine dioxide disinfection, money, business
## Q4 2026 Results
Tristel plc CEO Chris Lee presented Q4 2026 earnings with a focus on chlorine dioxide disinfection technology.
## Company Background
Tristel is a chemistry company operating in high-level disinfection with proprietary chlorine dioxide technology to prevent microbial transmission.
## CEO Experience
Chris Lee has 35+ years in med tech, including 18 years at Johnson & Johnson and leadership roles at Summit Medical.
## Key takeaway

Tristel plc's CEO Chris Lee presented Q4 2026 earnings with a focus on chlorine dioxide disinfection technology.